Feng Lin^1*, Samy Gallienne^2*, Raluca Ionescu-Ittu^2*, Medha Sasane^1*, Ani Minasyan^1*, Christina Tekle^1* and Joshua Richter, MD³

¹Sanofi, Cambridge, MA
²STATLOG, Montreal, Canada
³Mount Sinai, New York, NY

Dawn Swan, MRCP, FRCPath^1*, Marsali Maclean^1*, Niamh Waters, MBBS^2*, Denise Lee, MBBS^2*, Charmaine Smith^3*, Arina Martynchyk^1*, Eliza A. Hawkes, MD⁴ and Jay Hocking, MBBS, FRACP, FRCPA, PhD^1*

¹Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia
²Austin Hospital, Melbourne, VIC, Australia
³Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, VIC, Australia
⁴Olivia Newton-John Cancer Research Institute, Melbourne, Australia

Anne-Valérie Keller, MSc^1*, Marina Hajiyianni^2*, Eileen Kurre^1*, Elias Karl Mai, MD^1,2*, Uta Bertsch, MD^1,2,3*, Axel Benner^4*, Steffen Luntz, MD^5*, Marc-Steffen Raab^1,2*, Britta Besemer, MD^6*, Christian Sebastian Michel, MD^7*, Roland Schroers, MD^8*, Roland Fenk, MD, PhD^9*, Hans Salwender, MD^10*, Igor Wolfgang Blau, MD, PhD^11*, Mathias Hänel, MD¹², Christoph Mann, MD^13* and Hartmut Goldschmidt, MD^1,2,3

¹Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Studygroup, Heidelberg University Hospital, Heidelberg, Germany
²Department of Medicine V, Heidelberg Myeloma Center, University Hospital Heidelberg, Heidelberg, Germany
³National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
⁴Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁵Coordination Centre for Clinical Trials (KKS), Heidelberg, Germany
⁶Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany
⁷Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany
⁸Medical Clinic, University Hospital Bochum, Bochum, Germany
⁹Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
¹⁰Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona, Hamburg, Germany
¹¹Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany
¹²Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
¹³Department of Haematology, Oncology and Immunology, Philipps-University Marburg, Marburg, Germany

Jeremie Zerbit, PharmD, PhD^1*, Guillemette Fouquet, MD, PhD^2*, Marion Detroit, PharmD, PhD^3*, Sylvain Choquet, MD^4*, Laurent Garderet^5*, Olivier Hermine, MD, PhD⁶, Clarisse Cazelles, MD^6*, Laurent Frenzel, MD, PhD^6*, Mohamad Mohty, MD, PhD⁷, Zoe Van De Wyngaert, MD^7*, Harel Stephanie, MD^8*, Karim Belhadj Merzoug, MD, PhD^9*, Sabine Brechignac, MD^10*, Didier Bouscary, MD, PhD^11*, Cyrielle Rodier, MD^11*, Romain Winer, PharmD^1*, Mathis Collier, PhD^12* and Marguerite Vignon, MD^11*

¹Hospital at Home, Greater Paris University Hospitals (AP-HP), Paris, France
²Hematology, Hospital Sud Francilien, Corbeil-Essonnes, France
³Pharmacy, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁴Pitie-Salpetriere Hospital, Paris, France
⁵Hematology, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁶Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁷Hematology, Saint-Antoine Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁸Immuno-hematology, Saint-Louis Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁹Unit of Lymphoid Hemopathies, Henri Mondor Hospital, Greater Paris University Hospitals (AP-HP), Creteil, France
¹⁰Clinical Hematology, Avicenne Hospital, Greater Paris University Hospitals (AP-HP), Bobigny, France
¹¹Hematology, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
¹²Clinical Research Unit, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France

Gabriel Najarro, PA-C, MMSc^1*, Vikas A. Gupta, MD PhD², Nisha S. Joseph, MD², Jonathan L. Kaufman, MD², Ajay K. Nooka, MD, MPH³, Madhav V. Dhodapkar, MD PhD², Sagar Lonial, MD^2* and Craig C. Hofmeister, MD⁴

¹Emory University, Atlanta, GA
²Winship Cancer Institute of Emory University, Atlanta, GA
³Winship Cancer Institute of Emory University, Atlanta
⁴Emory Digital, Emory University, Atlanta, GA

Nadine Abdallah, MD¹, Jay R. Hydren, PhD², Mason S. Barnes, B.S.^2*, Andrew Wood, BS^2*, Sascha Alexander Tuchman, MD, MHS³, Jeffrey A. Zonder, MD ⁴, Giada Bianchi, MD⁵, Heather J. Landau, MD⁶, Muhamed Baljevic, MD⁷, James E. Hoffman⁸, Ana M. Sahagun Sanchez Aldana, MS^2*, Jorge Arturo Hurtado Martinez, MD^2*, Jennifer M. Ahlstrom, BA^2* and Morie A. Gertz, MD⁹

¹Mayo Clinic, Rochester, MN
²HealthTree Foundation, Lehi, UT
³University of North Carolina, Durham, NC
⁴Karmanos Cancer Institute, Detroit, MI
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
⁸Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁹Division of Hematology, Mayo Clinic, Rochester, MN

Karen Sweiss, PharmD¹, Jay R. Hydren, PhD², Jorge Arturo Hurtado Martinez, MD^2*, Mason S. Barnes, B.S.^2*, Pritesh Patel, MD^3*, Douglas W. Sborov, MD, MS⁴, Jennifer M. Ahlstrom, BA^2*, Lisa Sharp, PhD, BSN, MA^5* and Craig C. Hofmeister, MD⁶

¹Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
²HealthTree Foundation, Lehi, UT
³Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
⁴University of Utah School of Medicine, Salt Lake City, UT
⁵University of Illinois at Chicago, Chicago, IL
⁶Winship Cancer Institute of Emory University, Atlanta, GA

Apoorva Doshi, MBBS^1*, Gayathri Ravi, MD², Susan Bal, MD², Supriya Maheshwari, MBBS^3*, Kelly Godby^4*, Luciano J. Costa, MD, PhD², Joshua Richman^5*, Grant Williams, MD^2*, Smita Bhatia, MD, MPH⁴ and Smith Giri^4*

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
³University of Alabama at Birmingham, Birimingham, AL
⁴University of Alabama at Birmingham, Birmingham, AL
⁵Department of Surgery, University of Alabama at Birmingham, Birmingham, AL

Nora Balas, PhD^1*, Joshua Richman^2*, Wendy Landier, PhD^3*, Sadeep Shrestha, PhD^4*, Katia J Bruxvoort, PhD^5*, Lindsey Hageman, MPH^1*, Qingrui Meng, MS^3*, Elizabeth Ross^5*, Alysia Bosworth, BA^6*, Hok Sreng Te^7*, F. Lennie Wong, PhD⁸, Ravi Bhatia, MD⁹, Stephen J. Forman, MD, FACP¹⁰, Saro Armenian, DO, MPH⁶, Daniel Weisdorf, MD⁷ and Smita Bhatia, MD, MPH¹

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
³University of Alabama At Birmingham, Birmingham, AL
⁴School of Public Health, University of Alabama at Birmingham, Birmingham, AL
⁵University of Alabama at Birmingham, Birmingham, AL
⁶City of Hope National Medical Center, Duarte, CA
⁷University of Minnesota, Minneapolis, MN
⁸City of Hope, Duarte, CA
⁹Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
¹⁰Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Betty Gration, BMBCh, MRCP, BSc, M.Bioch^1*, Cameron Wellard, BSc (Hons), PhD^2*, Elizabeth Moore, PhD, MPH, PgradDip (Nurs Crit Care)^2*, Peter Mollee, FRACP, MBBS, MSc, FRCPA³, Ian H. Kerridge, FRACP, FRCPA, MPhil, BA^4*, Andrew Spencer, MBBS^5,6*, Anita Shetty, MD^7*, Bart Baker^8*, Cecily Forsyth, MD⁹, Jessica Heenan, MBBS, FRACP, FRCPA^10*, Zoe K McQuilten, MBBS, PhD¹¹, Erica M. Wood, MD^11,12 and Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA^1*

¹Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
²School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
³Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁴Royal North Shore Hospital, Sydney, Australia
⁵Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia
⁶School of Translational Medicine, Alfred Health-Monash University, Melbourne, VIC, Australia
⁷Nepean Hospital, Penrith, Australia
⁸Palmerston North Hospital, Palmerston North, New Zealand
⁹Central Coast Local Health District (Gosford and Wyong Hospitals), Gosford, Australia
¹⁰Department of Haematology, Holman Clinic, Launceston General Hospital, Tasmania, Australia, Launceston, TAS, Australia
¹¹Department of Haematology, Monash Health, Melbourne, Australia
¹²Monash University, Melbourne, Australia

Maria Queralt Salas, MD^1*, Maria Teresa Solano^2*, Mónica Baile González, MD^3*, Marina Acera Gómez^3*, Maria Laura Fox, MD^4*, Maria del Mar Pérez Artigas^4*, Ana Santamaria, MD^5*, María del Carmen Quintela González^5*, Andres Sanchez Salinas, MD^6*, Joaquina Salmeron Camacho^7*, Veronica Illana Álvaro^8*, Zahra Abdallahi Lefdil^8*, Sara Fernandez-Luis, MD^9*, Leddy Patricia Vega Suárez^9*, Javier Cornago, MD^10*, Laura Pardo, MD^10*, Sara Villar, MD^11*, Patricia Beorlegui Murillo^12*, Albert Esquirol, MD^13*, Isabel Izquierdo, MD^14*, Sonia González Rodriguez^15*, Alberto Mussetti, MD^16*, Aitor Abuin Blanco, MD^17*, Silvia Filafferro^18*, Pascual Balsalobre^19*, Leyre Bento De Miguel^20* and Ana Maria Sureda Balari, MD, PhD²¹

¹Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
²Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
³Servicio de Hematología y Hemoterapia del Complejo Asistencial Universitario de Salamanca -IBSAL, Salamanca, Spain
⁴Vall d'Hebron University Hospital, Barcelona, Spain
⁵Hospital Álvaro Cunqueiro, Vigo, Spain
⁶Hematology Department, Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
⁷Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
⁸Hospital Universitario de la Princesa, Madrid, Spain
⁹Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
¹⁰Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹¹Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
¹²Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Navarra, Spain
¹³Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
¹⁴Hospital Universitario Miguel Servet, Zaragoza, Spain
¹⁵Institut Catala d’Oncologia-Hospitalet, Clinical Hematology Department, Barcelona, Spain
¹⁶Clinical Hematology Department, Institut Catala d’Oncologia-Hospitalet, L'Hospitalet De Llobregat, Barcelona, Spain
¹⁷University Hospital of Santiago De Compostela, SANTIAGO DE COMPOSTELA, ESP
¹⁸Grupo EspañOl De Trasplante De Progenitores HematopoyéTicos Y Tera, Madrid, ESP
¹⁹Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC), Madrid, AL, Spain
²⁰Hematology Department, Son Espases University Hospital, IdISBa, Palma De Mallorca, Spain
²¹Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain

Binoy Yohannan, MD^1,2, Angela Dispenzieri, MD¹, Francis Buadi, MD¹, David Dingli, MD, PhD¹, Nelson Leung, MD¹, Prashant Kapoor, MD³, Wilson I. Gonsalves, MD⁴, Taxiarchis Kourelis, MD¹, Joselle Cook, MBBS¹, Moritz Binder, MD¹, Suzanne R Hayman, MD¹, Yi Lin, MD, PhD¹, Ronald S Go, M.D.¹, Rahma M Warsame, MD¹, Vincent Rajkumar, MD^1*, Shaji Kumar, MD¹, Eli Muchtar, MD¹, Hassan B Alkhateeb, MD^1*, William J. Hogan, MD¹, Mark R. Litzow, MD¹, Mrinal M. Patnaik, MD, MBBS³, Aref Al-Kali, MD¹, Abhishek Mangaonkar, MD^5*, Robert C Wolf, Pharm.D, R.Ph.^6*, Mithun V Shah, M.D., Ph.D.¹ and Morie A. Gertz, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
³Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
⁵Division of Hematology, Mayo clinic, Rochester, MN
⁶Department of Pharmacy, Mayo Clinic, Rochester, MN

Sandra CM Quinn, PhD, BA^1* and Danielle Romaniuk^2*

¹Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
²Research and Advocacy, Myeloma UK, Edinburgh, Scotland, United Kingdom

Smith Giri^1*, Liton Francisco^1*, Nicole Rafalko^2,3*, Niodita Gupta-Werner^3*, Joshua Richman^4*, Smita Bhatia, MD, MPH⁵, Kelly Godby^1*, Gayathri Ravi, MD¹, Susan Bal, MD^1*, Marjohn Armoon, PharmD^6*, Rohan Medhekar^3* and Luciano J. Costa, MD, PhD¹

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²Drexel University, Philadelphia, PA
³Janssen Scientific Affairs, LLC, Horsham, PA
⁴Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
⁵Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁶Medical Director, Multiple Myeloma, Hematology US Medical Affairs, Janssen Scientific Affairs, LLC, Horsham, PA

Craig C. Hofmeister, MD¹, Mingyuan Zhang, MS^2*, Vikas A. Gupta, MD PhD³, Nisha S. Joseph, MD³, Jonathan L. Kaufman, MD³, Ajay K. Nooka, MD, MPH⁴, Madhav V. Dhodapkar, MD PhD³, Sagar Lonial, MD^3* and Douglas W. Sborov, MD, MS⁵

¹Emory Digital, Emory University, Atlanta, GA
²Data Science Service, University of Utah, Salt Lake City, UT
³Winship Cancer Institute of Emory University, Atlanta, GA
⁴Winship Cancer Institute of Emory University, Atlanta
⁵Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT

Carmine Liberatore^1*, Paola Tacchetti, MD, PhD^2*, Concetta Conticello, MD^3*, Gregorio Barila^4*, Elisabetta Antonioli^5*, Angelo Belotti, MD^6*, Anna Maria Cafro, MD^7*, Laura Paris, MD^8*, Velia Bongarzoni^9*, Massimo Gentile, MD^10*, Matteo DA VIA, MD^11*, Barbara Gamberi, MD^12*, Sara Pezzatti^13*, Fabrizio Ciambelli, MD^14*, Mariagrazia Garzia^15*, Ombretta Annibali, MD^16*, Francesca Fazio^17*, Giusy Antolino^18*, Nicola Sgherza^19*, Francesca Farina^20*, Annalisa Citro^21*, Monica Galli^22*, Vittorio Del Fabro^23*, Claudio Salvatore Cartia, MD^24*, Francesca Fioritoni^25*, Katia Mancuso, MD, PhD^2,26*, Irene Attucci^27*, Maria Luisa Pioltelli^28*, Michele Puppi, MD^29*, Sofia Terlizzi^30*, Chiara Lisi^31*, Virginia Valeria Ferretti^32*, Massimo Offidani, MD ^33*, Maria Teresa Petrucci, MD^31* and Silvia Mangiacavalli, MD^24*

¹Hematology Unit, Department of Oncology and Hematology,, Ospedale Santo Spirito, Pescara, ITA
²Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
³AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania, Italy, Catania, ITA
⁴Hematology Unit, Ospedale San Bortolo, Vicenza, Italy
⁵Careggi Hospital and University of Florence, Firenze, Italy
⁶Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
⁷Department of Hematology, GOM Niguarda Hospital, Milan, Milan, ITA
⁸Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁹Department of Hematology, San Giovanni-Addolorata Hospital, ROMA, ITA
¹⁰Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy, Cosenza, Italy
¹¹Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
¹²Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
¹³Department of Hematology and Transplantation, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, St Gerardo Hospital, Monza, Italy
¹⁴SC Ematologia, ASST Valle Olona - Ospedale di Circolo, Busto Arsizio, Italy
¹⁵Azienda Ospedaliera San Camillo Forlanini, UOC Hematology and stem cell transplant, Roma, ITA
¹⁶Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
¹⁷Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, ROMA, Italy
¹⁸Multiple Myeloma GIMEMA Lazio Group, rome, ITA
¹⁹Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy
²⁰Hematology and BMT unit, IRCCS Ospedale San Raffaele, Milano, Italy
²¹UOC Ematologia, Ospedale Civile di Legnano, Legnano, Italy
²²Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
²³Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, ITA
²⁴Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²⁵Department of Haematology, Pescara, ITA
²⁶Department of Medical and Surgical Science, DIMEC, University of Bologna, Bologna, ITA
²⁷Careggi University Hospital, florence, Italy
²⁸Department of Hematology, GOM Niguarda Hospital, Milan, ITA
²⁹Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
³⁰Department of Hematology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy
³¹Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
³²Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
³³Clinica di Ematologia Ospedali Riuniti Ancona, Ancona, Italy

Frances N. Cervoni Curet, MD^1*, Roland L. Bassett, MS^2*, Oren Pasvolsky, MD³, Abdullah Faisal Deen^1*, Mark R. Tanner, PhD^1*, Qaiser Bashir, MD¹, Samer A. Srour, MD¹, Neeraj Y. Saini, MD¹, Jeremy Ramdial, MD¹, Yago Nieto, MD, PhD¹, Hans C. Lee, MD³, Krina K. Patel, MD, MSc³, Partow Kebriaei, MD¹, Warren B. Fingrut, MD^1*, Portia Smallbone, MD^1*, Melody R. Becnel, MD³, Mahmoud R. Gaballa, MD³, Sheeba K. Thomas, MD³, J Christine Ye, MD^3*, Robert Z. Orlowski, MD, PhD³, Richard E. Champlin, MD¹, Elizabeth J. Shpall, MD¹ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Andrea Tufano-Sugarman, MD¹, Shahidul Islam, DrPH, MPH, PStat^2*, Faith E Davies, MD³, Gareth Morgan, M.D., Ph.D.^3*, David Kaminetzky, MD^3*, Oscar B Lahoud, MD⁴ and Marc J Braunstein, MD, PhD⁵

¹NYU Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine, Mineola, NY
²Biostatistics Unit, Office of Academic Affairs, Northwell Health, New Hyde Park, NY
³NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
⁴NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, Brooklyn, NY
⁵NYU Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine, Great Neck, NY

Martin Stork^1*, Jakub Radocha, MD, PhD^2*, Tomas Jelinek, MD, PhD^3*, Ivan Spicka, CSc^4*, Tomas Pika^5*, Alexandra Jungova^6*, Jan Straub^7*, Jiri Minarik⁸, Ivanna Boichuk^9*, Dominik Fric^9*, Denisa Novakova^2*, Tereza Popkova, MD^10*, Lenka Polcerova^11*, Vladimir Maisnar, MD, PhD^12*, Ludek Pour, PhD^1* and Roman Hajek, MD, PhD¹³

¹Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
²4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University Czech Republic, Hradec Kralove, Czech Republic
³Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic
⁴1st Medical Department – Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic, Prague, Czech Republic
⁵Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
⁶Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic
⁷1st Medical Department – Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic
⁸Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic
⁹Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic
¹⁰Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
¹¹Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic, Brno, Czech Republic
¹²4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
¹³University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic

Cesar Rodriguez, MD^1*, Hsien-Yen Chang, PhD^2*, Yi-Hsuan Liu, PhD, MS, RD^2*, Jinghua He^2*, Hoa H. Le, PhD^2*, Jessica Maitland^3*, Alvi A. Rahman^3*, Anabelle Tardif-Samson^3*, Bronwyn Moore^3*, Marie-Hélène Lafeuille, MA^3*, Saurabh N. Patel, MD^2* and Xinke Zhang, PhD^2*

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Johnson & Johnson Innovative Medicine, Horsham, PA
³Analysis Group, Inc., Montreal, QC, Canada

Esraa Abdalla, PharmD^1*, Malak Alharbi, MBBS^1*, Sawyer Bawek, DO², Catherine Forbes, PharmD^1*, Ian Lund, PA-C^1*, Han Yu, PharmD, MS, MA^1*, Berthliz Durand, Pharmacy Candidate^2*, Jens Hillengass, MD, PhD³, Hamza Hassan, MD^1* and Eugene Przespolewski, PharmD^1*

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²University at Buffalo, Buffalo, NY
³Department of Medicine - Myeloma, Roswell Park, Buffalo, NY

Wenjing Wang, MD^1,2*, Jing Li, MD^1*, Mengyuan Li^3,4*, Xiao He^5*, LI Bao^6*, Xiaoqiong Tang^7*, Hua Xue^8*, Jianmei Xu^8*, Liye Zhong, MD, PhD^9* and Peng Liu, MD^1,2

¹Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
²Department of Hematology, Shanghai Geriatric Medical Center, Shanghai, China
³School of Medicine South China University of Technology, Guangzhou, China
⁴Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
⁵Department of Hematology, Xiangya Hospital, Central South University, Changsha, China
⁶Beijing Jishuitan Hospital, Beijing, Beijing, CHN
⁷Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
⁸Affiliated Hospital of Hebei University, Baoding, China
⁹Department of Haematology, The First Affiliated Hospital of JINAN University, Guangzhou, China

Amna Gul, MD^1*, Yumna Afaq, MBBS^2*, Talha Khan, MBBS^3*, Mahnoor Asghar Keen, MD, MBBS^3*, Shayan Ahmad, MBBS^3*, Mahd Aftab Khan, MD^4*, Rida Hussain, MD^5*, Arslan Inayat, MD^6*, Danish Safi, MD⁷ and Salahuddin Safi, MD^8*

¹Miami Cancer Institute, Miami, FL
²Khyber Medical College, Peshawar
³Khyber Medical College, Peshawar, Pakistan
⁴West Virginia University, Morgantown, WV
⁵Camden Clark Medical Center, Parkersburg, WV
⁶HSHS St.Mary's Hospital, Decatur
⁷Department of Medical Oncology, West Virginia University Cancer Institute, Morgantown, WV
⁸West Virginia University Cancer Institute, Morgantown, WV

Gabriela A Abreu, PhD^1*, Juliana Queiroz^1*, Thiago Luiz Nogueira da Silva^1*, Claudia R Soares^1*, Patricia Menezes^1*, Mariano Carrizo^2*, Tatiana Ricca^1*, Tatiana Pires^1*, Straus Tanaka^1*, Lucas Perelli^2*, Graziela Bernardino^1*, André Luiz Alves Ribeiro de Souza^3*, Ventura Simonovich^4*, Paula Scibona^5*, Cristian M Seehaus^6*, Erika B Brulc^6,7*, Natalia Kim^8* and Laura Jotimliansky^9*

¹GSK, Rio de Janeiro, Brazil
²GSK, Buenos Aires, Argentina
³Orizon (at the time of data acquisition), São Paulo, Brazil
⁴Oncological Gynecology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁵Clinical Pharmacology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁶Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁷Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
⁸GSK, London, United Kingdom
⁹GSK (at the time of data acquisition), Buenos Aires, Argentina

Michael Weise, PharmD^1,2*, Shebli Atrash, MD^2,3, Briha Ansari^4*, Muhammad Umair Mushtaq^2,5, Joseph P. McGuirk, DO⁵, Al-Ola Abdallah, MD^2,5, Zahra Mahmoudjafari, PharmD^2,5* and Nausheen Ahmed, MD^2,6

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁴Johns Hopkins University, Baltimore
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁶University of Kansas Cancer Center, Kansas City, KS

Fathima Shehnaz Ayoobkhan, MD^1,2, Raabia Qureshi^3,4*, Raeef L Rahman, BS^5,6, Zohaa Faiz^3*, Sohaib Irfan, MD^3*, Ahmad Iftikhar, MD^7*, Briha Ansari^8*, Muhammad Umair Mushtaq, MD^5,9, Al-Ola Abdallah, MD^5,10, Shahzad Raza, MD¹¹, Hira Shaikh, MD^5,12, Forat Lutfi, MD^5,13, Shebli Atrash, MD^5,14, Joseph P. McGuirk, DO^5,15, Hamza Sloan Hashmi, MD^16,17*, Faiz Anwer, MD^5,11 and Nausheen Ahmed, MD^5,18

¹U.S. Myeloma Innovations Research Collaborative., kansas
²Trinity Health Oakland, Pontiac, MI
³U.S. Myeloma Innovations Research Collaborative., Kansas
⁴University of Missouri Medical Center, Kansas
⁵US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁶School of Medicine, University of Kansas Medical Center, Kansas City, KS
⁷University of Arizona, Tucson, AZ
⁸Johns Hopkins University, Baltimore
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
¹⁰University of Kansas Cancer Center, Fairway, KS
¹¹Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
¹²University of Iowa Caver College of Medicine, Coralville, IA
¹³University of Kansas Medical Center, Westwood, KS
¹⁴Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
¹⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS
¹⁶Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
¹⁷US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
¹⁸University of Kansas Cancer Center, Kansas City, KS

Maria-Victoria Mateos, MD, PhD¹, Fernando Escalante^2*, Natalia Marin Huarte^3*, Angela Garcia Garcia-Porrero^3*, Miguel Jesús Villanueva Forero, MD³, Rafael Rios Tamayo, MD, PhD^4*, Antonia Sampol Mayol, MD^5*, Eugenio Gimenez^6*, Jose-Angel Hernandez Rivas, MD, PhD^7*, Savana Research Group^8* and Joaquin Martinez Lopez, PhD, MD^9*

¹University Hospital of Salamanca, Salamanca, Spain
²Complejo Asistencial Universitario de León, León, Spain
³Janssen-Cilag, S.A., Madrid, ESP
⁴Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, ESP
⁵Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
⁶Hospital Universitario Infanta Sofía, Madrid, Spain
⁷Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
⁸Savana Reseach, Madrid, Spain
⁹Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

Carina E. Ferraris^1*, Xiaoyin Li^2*, Gabriel De Avila^3*, Lisa M. Gudenkauf^4*, Aasha I. Hoogland^2*, Oanh Nguyen^4*, Yvelise Rodriguez^2*, Sylvia L. Crowder^4*, Nathan Parker, PhD, MPH^2*, Tiffany L. Carson^4*, Rachid C. Baz⁵, Kenneth H. Shain, MD, PhD⁶, Brandon Blue³, Ariel Grajales-Cruz, MD⁷, Melissa Alsina, MD⁷, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP⁸, Omar Castaneda, MD⁸, Taiga Nishihori, MD⁹, Hien Liu, MD⁷, Frederick L. Locke, MD¹⁰, Heather S.L. Jim, PhD^2*, Doris K. Hansen, MD⁸, Lauren C. Peres, PhD, MPH^11* and Laura B. Oswald, PhD^2*

¹College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale
²Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
³H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶H. Lee Moffitt Cancer Center, Tampa, FL
⁷Moffitt Cancer Center, Tampa, FL
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹⁰Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹¹Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL

Carlyn Rose Tan, MD¹, Sireesha Asoori, MBBS, MPH^2*, David Nemirovsky^3*, Andriy Derkach, PhD^3*, Larissa Brunaldi^4*, Rakesh Popat⁵, Chris Lau^5*, Efstathios Kastritis, MD^6*, Joaquín Martínez-Lopez^7*, Radhika Bansal, MBBS^4*, Andre De Menezes Silva Corraes, MD^4*, Saurabh Chhabra, MD⁸, Ricardo D. Parrondo, MD⁹, Sikander Ailawadhi, MD¹⁰, Despina Fotiou, MD^11*, Meletios Dimopoulos, MD¹¹, Kwee Yong, MD, PhD⁵, Catriona Mactier, MD^5*, Magdalena Corona^7*, Adolfo Jesús Sáez Marín, MD^7*, Hira Mian, MD¹², Saad Z. Usmani, MD¹³, Brian G.M. Durie¹⁴, Thomas G. Martin, MD¹⁵ and Yi Lin, MD, PhD¹⁶

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²University of California, San Francisco, CA
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Mayo Clinic Cancer Center, Rochester, MN
⁵Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁶Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece
⁷University of Complutense, Hospital 12 de Octubre, Madrid, Spain
⁸Division of Hematology, Mayo Clinic, Phoenix, AZ
⁹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
¹⁰Division of Hematology, Mayo Clinic, Jacksonville, FL
¹¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹²McMaster University, Hamilton, ON, Canada
¹³Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴International Myeloma Foundation, Studio City, CA
¹⁵University of California, San Francisco, San Francisco, CA
¹⁶Division of Hematology, Mayo Clinic, Rochester, MN

Diana Basali, MD¹, Heather McKee Hurwitz, PhD^2*, Kim Bell, MBA, RN, BSN^2*, Kimberly Sanders, BA^2*, Mark Ribbins, BA^2*, Raymond Jackson, BA^2* and Jason Valent, MD³

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Pepper Pike, OH
²Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Omar Castaneda, MD¹, Doris K. Hansen, MD², Mariola A Vazquez-Martinez, MD¹, Shrikar Modukuri^3*, Brandon Blue⁴, Julia Fadul, PharmD^5*, Ariel Denson, PharmD^6*, Parker Melnick, BS^5*, Filip Ionescu, MD, MS³, Kristy Harvey^5*, Blanca Lopez^3*, Katherine Tobon, PharmD, BS^7*, Hien Liu, MD³, Jose L. Ochoa-Bayona, MD^3*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP⁸, Taiga Nishihori, MD³, Kenneth H. Shain, MD, PhD⁹, Rachid Baz, MD¹⁰, Melissa Alsina, MD³, Ariel Grajales-Cruz, MD³, Allison Graeter, MD¹¹ and Frederick Locke, MD¹²

¹H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²H. Lee Moffitt Cancer Center & Research Institute, Tampa
³Moffitt Cancer Center, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa
⁶Department of Pharmacy, Moffitt Cancer Center, Tampa, FL
⁷Department of Pharmacy, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹H. Lee Moffitt Cancer Center, Tampa, FL
¹⁰Moffitt cancer center and research institute, tampa, FL
¹¹University of South Florida, Tampa, FL
¹²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Maya D. Srinivasan, MD, MSc^1,2, John Culnan, PhD^3*, Mehar Hora, BS^1*, Alexander Lazzaro, MD^1,2*, Britney Bell, MD^1,2, Geethika Bodanapu, BA¹, Cenk Yildirim, MS^3,4*, June Corrigan, MS^3*, Nhan V. Do, MD, MS^1,3*, Mary T. Brophy, MD^1,3*, Nikhil C. Munshi, MD^3,5,6, Raphael E. Szalat, MD, PhD^1,2, Nathanael R. Fillmore, PhD^2,3,6* and Camille V. Edwards, MD^1,2

¹Boston University Chobanian & Avedisian School of Medicine, Boston, MA
²Section of Hematology and Medical Oncology, Boston Medical Center, Boston, MA
³VA Boston Healthcare System, Boston, MA
⁴Massachusetts Veterans Epidemiology Research and Information Center, Boston
⁵Dana-Farber Cancer Institute, The Jerome Lipper Multiple Myeloma Center, Boston, MA
⁶Harvard Medical School, Boston, MA

Haiqiong Zheng^1*, Shi Han^2*, Houli Zhao^2*, Yongxian Hu^3* and He Huang, MD^4*

¹Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China, AL, China
²Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
³Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China

Rahul Banerjee, MD, FACP¹, Hsien-Yen Chang, PhD^2*, Yi-Hsuan Liu, PhD, MS, RD^2*, Hoa H. Le, PhD^2*, Helen Pai, MS^2*, Saurabh N. Patel, MD^2* and Xinke Zhang, PhD^2*

¹Fred Hutchinson Cancer Center, Seattle, WA
²Johnson & Johnson Innovative Medicine, Horsham, PA

Alissa Visram, MD, MPH¹, Rajshekhar Chakraborty, MD², Gregory R Pond, PhD^3*, Hsien Seow^4*, Anastasia Gayowsky^5*, Ghulam Rehman Mohyuddin, MD⁶, Samer Al Hadidi, MD, MSc⁷, Alejandro Garcia-Horton^8*, Rafael Fonseca, MD⁹ and Hira Mian, MD¹⁰

¹Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
²Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
³Department of Oncology, McMaster University, Hamilton, Canada
⁴Department of Oncology, McMaster University, Hamilton, ON, Canada
⁵Institute for Clinical Evaluative Sciences, McMaster University, Hamilton, ON, Canada
⁶Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁷University of Arkansas for Medical Sciences, Little Rock, AR
⁸McMaster University, Hamilton, ON, CAN
⁹Division of Hematology, Mayo Clinic, Paradise Valley, AZ
¹⁰McMaster University, Hamilton, ON, Canada

Hira Shaikh, MD^1,2, Jonathan Lochner, PharmD^3*, Bradley Loeffler^4*, Reed Friend, MD^2,5, Alma Habib, MD^2,6, Marshall McKenna, MD^2,7*, Jordan Snyder, PharmD^2,8*, James A Davis, PharmD^2,9*, Gina Patrus^2,10*, Rachel Dileo^2,11*, Prerna Mewawalla^12,13*, Kimberly M Green, DO^2,9*, Muhammad Umair Mushtaq, MD^2,8, Christopher Strouse, MD^2,14, Yun Kyoung Tiger, MD, PhD^2,7, Al-Ola Abdallah, MD^2,15, Nausheen Ahmed, MD^2,16, Abdullah Mohammad Khan, MD, MBBS^2,6, Hamza Sloan Hashmi, MD^9,17,18*, Barry Paul, MD, MS^2,5 and Shebli Atrash^2,19*

¹Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁴Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
⁵Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁶Division of Hematology, The Ohio State University, Columbus, OH
⁷Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁸Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
⁹Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹⁰Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA
¹¹Allegheny Health Network Research Institute, Cranberry Twp, PA
¹²Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
¹³US Myeloma Innovations Research Collaborative (USMIRC), kansas city, KS
¹⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
¹⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹⁷Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
¹⁸US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
¹⁹Levine Cancer, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC

Mehndi Dandwani, MBBS¹, Aliya Rashid, DO, MPH^2,3, Donald C Moore, PharmD, BCPS, BCOP, DPLA, FCCP^4*, Julia Balmaceda, MD^5*, Belal Abousaida, MD, PhD^5*, Aishwarya Sannareddy, MBBS^6*, Paige Laverick^7*, Prerna Rastogi, MD, PhD^8*, Abdullah Thayyil^8*, James A Davis, PharmD^2,9*, Kimberly M Green, DO^2,9*, Christopher Strouse, MD^2,10, Aimaz Afrough^2,6*, Barry Paul, MD, MS^2,4, Hamza Sloan Hashmi, MD^9,11,12*, Larry D Anderson Jr., MD, PhD⁶, Nausheen Ahmed, MD^2,13, Al-Ola Abdallah, MD^2,14, Shebli Atrash^2,15* and Hira Shaikh, MD^2,10

¹University of Iowa Healthcare, Iowa, IA
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
⁴Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁵University of Kansas Medical Center, Kansas City
⁶Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁷Medical University of South Carolina, Charleston, SC
⁸University of Iowa Healthcare, Iowa City, IA
⁹Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹⁰Division of Hematology, Oncology, and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
¹¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
¹²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
¹³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁵Levine Cancer, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC

Muhammad Salman Faisal, MD, MBBS¹, Muhammad Talha Shaukat^2*, Wania Ur Rehman^2*, Mariam Shahabi^3*, Muhammad Shahzaib^2*, Ali Mohsin^4*, Zunaira Amjad^5*, Aqeeb Ur Rehman^6*, Zainab Sajjad^2*, Aleenah Mohsin^7*, Shammas Bajwa, MD^8* and Silas Day, MS^9*

¹University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK
²King Edward Medical University, Lahore, Pakistan
³Dow University of Health Sciences, Karachi, Pakistan
⁴Shalamar Medical and Dental College, Lahore, Pakistan
⁵Services Institute of Medical Sciences, Lahore, Pakistan
⁶University of Alabama at Birmingham, Birmingham, AL
⁷Brown University, Providence, RI
⁸Internal Medicine Department, Oklahoma University Medical Center, Oklahoma City, OK
⁹Hematology/Oncology Clinical Trials Office, OU Health Stephenson Cancer Center, Oklahoma City, OK

Henry Becerra, MD¹, Mustafa Wasifuddin, MD^1*, Ifeanyi Nnamdi Uche, MBBS², Nosakhare Paul Ilerhunmwuwa, MBBS, MSc³, Narek Hakobyan, MD¹, Dosbai Saparov, MD^1*, Shakirat Gold-Olufadi, MBBS⁴, Philipp Barakat, MD^5*, Ayesha Nayab Nasir, MD^5*, Victor Sebastian Arruarana, MD^5*, Neharika Shrestha, MBBS⁵, Omid Heravi, MD⁶, Beka Aroshidze, MD⁶, Hesham Abowali, MD^6*, Ruchi Yadav, MD⁶, Akriti Pokhrel, MBBS^6*, Jin Zheng, MD, PhD⁶, Muhammad Tahir, MD^7*, Pei-Ting Chen, MD^5*, Amulya Bellamkonda, MD^7* and Jen-Chin Wang, MD⁸

¹Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
²Department of Medicine, One Brookdale University Hospital and Medical Center, Brooklyn, NY
³Department of Hematology, University of Pittsburgh Medical Center, Brooklyn, NY
⁴Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
⁵Brookdale University Hospital and Medical Center, Brooklyn, NY
⁶Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
⁷Hematology and Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
⁸Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Long Beach, NY

Beth M. Faiman, PhD, CNP¹, Louis S Williams, MD¹, Jack Khouri, MD², Faiz Anwer, MD², Shahzad Raza, MD^2,3, Christy J. Samaras, DO², Kimberly Hamilton, CNP^4*, Cynthia Scott, CNP^1*, Saveta Mathur, CNP^3*, Omer N. Koc, MD⁵, Willem J. van Heeckeren, MD⁶, Jason Valent, MD² and Sandra Mazzoni, DO⁷

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁴Cleveland Clinic Taussig Cancer Institute, CLEVELAND, OH
⁵Cleveland Clinic Foundation, Beachwood, OH
⁶Taussig Cancer Institute, Cleveland Clinic, Mayfield Heights, OH
⁷Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH